Page last updated: 2024-10-28

hydralazine and Adenoma, Prolactin-Secreting, Pituitary

hydralazine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 2 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research Excerpts

ExcerptRelevanceReference
"In contrast, N2 breathing to terminal anoxia and intravenous hydralazine produced a negligible increase in Hb, but large reductions in HbO and HbT."1.33The effects of tumour blood flow and oxygenation modifiers on subcutaneous tumours as determined by NIRS. ( Connelly, JP; Griffiths, JR; Howe, FA; Robinson, SP; Springett, R, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howe, FA2
Connelly, JP1
Robinson, SP2
Springett, R1
Griffiths, JR2
Stubbs, M1

Other Studies

2 other studies available for hydralazine and Adenoma, Prolactin-Secreting, Pituitary

ArticleYear
The effects of tumour blood flow and oxygenation modifiers on subcutaneous tumours as determined by NIRS.
    Advances in experimental medicine and biology, 2005, Volume: 566

    Topics: Animals; Carbon Dioxide; Female; Hemoglobins; Hydralazine; Hyperoxia; Hypoxia; Magnetic Resonance Im

2005
Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels.
    British journal of cancer, 2000, Volume: 82, Issue:12

    Topics: Animals; Blood Glucose; Carbon Dioxide; Energy Metabolism; Female; Hydralazine; Magnetic Resonance I

2000